JP2013508348A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508348A5
JP2013508348A5 JP2012534793A JP2012534793A JP2013508348A5 JP 2013508348 A5 JP2013508348 A5 JP 2013508348A5 JP 2012534793 A JP2012534793 A JP 2012534793A JP 2012534793 A JP2012534793 A JP 2012534793A JP 2013508348 A5 JP2013508348 A5 JP 2013508348A5
Authority
JP
Japan
Prior art keywords
fatty acid
oil mixture
dha
epa
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012534793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508348A (ja
JP6116905B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/002854 external-priority patent/WO2011048493A1/en
Publication of JP2013508348A publication Critical patent/JP2013508348A/ja
Publication of JP2013508348A5 publication Critical patent/JP2013508348A5/ja
Application granted granted Critical
Publication of JP6116905B2 publication Critical patent/JP6116905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012534793A 2009-10-23 2010-10-22 脂肪酸油混合物の被覆型カプセル剤および錠剤 Active JP6116905B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US25429609P 2009-10-23 2009-10-23
US25429309P 2009-10-23 2009-10-23
US25429109P 2009-10-23 2009-10-23
US61/254,291 2009-10-23
US61/254,296 2009-10-23
US61/254,293 2009-10-23
PCT/IB2010/002854 WO2011048493A1 (en) 2009-10-23 2010-10-22 Coated capsules and tablets of a fatty acid oil mixture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015147073A Division JP6151317B2 (ja) 2009-10-23 2015-07-24 脂肪酸油混合物の被覆型カプセル剤および錠剤

Publications (3)

Publication Number Publication Date
JP2013508348A JP2013508348A (ja) 2013-03-07
JP2013508348A5 true JP2013508348A5 (cg-RX-API-DMAC7.html) 2017-02-02
JP6116905B2 JP6116905B2 (ja) 2017-04-19

Family

ID=43899870

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012534793A Active JP6116905B2 (ja) 2009-10-23 2010-10-22 脂肪酸油混合物の被覆型カプセル剤および錠剤
JP2015147073A Active JP6151317B2 (ja) 2009-10-23 2015-07-24 脂肪酸油混合物の被覆型カプセル剤および錠剤
JP2017102240A Active JP6835664B2 (ja) 2009-10-23 2017-05-24 脂肪酸油混合物の被覆型カプセル剤および錠剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015147073A Active JP6151317B2 (ja) 2009-10-23 2015-07-24 脂肪酸油混合物の被覆型カプセル剤および錠剤
JP2017102240A Active JP6835664B2 (ja) 2009-10-23 2017-05-24 脂肪酸油混合物の被覆型カプセル剤および錠剤

Country Status (9)

Country Link
US (1) US9370493B2 (cg-RX-API-DMAC7.html)
EP (1) EP2490678B1 (cg-RX-API-DMAC7.html)
JP (3) JP6116905B2 (cg-RX-API-DMAC7.html)
KR (4) KR20200013123A (cg-RX-API-DMAC7.html)
CN (1) CN102724972A (cg-RX-API-DMAC7.html)
AU (1) AU2010309517B2 (cg-RX-API-DMAC7.html)
CA (1) CA2781525C (cg-RX-API-DMAC7.html)
ES (1) ES2895477T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011048493A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2405902B1 (en) 2009-03-09 2021-07-21 Basf As Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
KR20200013123A (ko) * 2009-10-23 2020-02-05 바스프 에이에스 지방산 오일 혼합물의 코팅된 캡슐 및 정제
AR082930A1 (es) * 2010-09-08 2013-01-16 Pronova Biopharma Norge As Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina
EP2613767A4 (en) * 2010-09-08 2014-03-19 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
US20140004186A1 (en) * 2010-09-08 2014-01-02 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
US8697676B2 (en) 2011-06-15 2014-04-15 Ronald E Rosedale Omega-3 fatty acid nutriceutical composition and optimization method
SMT201800519T1 (it) 2012-01-06 2018-11-09 Omthera Pharmaceuticals Inc Composizioni di acidi grassi polinsaturi omega-3 in forma di acido libero arricchite in dpa
PT3072510T (pt) 2012-03-30 2019-08-22 Micelle Biopharma Inc Composições de éster de ácido gordo ómega-3
US9480651B2 (en) 2012-03-30 2016-11-01 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
US10898458B2 (en) 2012-03-30 2021-01-26 Micelle Biopharma, Inc. Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
US20160228397A1 (en) 2012-03-30 2016-08-11 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
US20130295173A1 (en) 2012-05-07 2013-11-07 Omthera Pharmaceuticals, Inc. Compositions of statins and omega-3 fatty acids
CN104968215B (zh) * 2012-12-12 2018-09-11 罗纳德·罗斯代尔 ω-3脂肪酸营养药组合物和优化方法
KR101534494B1 (ko) * 2014-01-09 2015-07-07 충남대학교산학협력단 Ｄｈａ를 포함하는 혈관 질환 예방 및 치료용 약학적 조성물
SG11201705938TA (en) * 2015-01-21 2017-08-30 Mochida Pharm Co Ltd SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
MA41611A (fr) * 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
WO2016179137A1 (en) * 2015-05-04 2016-11-10 Cytometix, Inc. Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
AU2017232554B2 (en) * 2016-03-16 2020-05-14 Golden Omega Norway As Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production
US11241408B2 (en) * 2016-08-12 2022-02-08 Pharmako Biotechnologies Pty Limited Omega-3 compositions and methods relating thereto
MY202587A (en) 2018-03-15 2024-05-09 Scherer Technologies Llc R P Enteric softgel capsules
TR201915787A2 (tr) * 2019-10-14 2021-04-21 Yilmaz Usta Duygu Bosentan monohi̇drat yüklenmi̇ş sivi kendi̇li̇ği̇nden nanoemülsi̇fi̇ye i̇laç taşiyici si̇stem ve tablet formülasyonu
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法
WO2025234509A1 (ko) * 2024-05-08 2025-11-13 코스맥스바이오 주식회사 pH 의존성 필름 조성물

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
EP0487575B1 (en) * 1989-08-17 1994-11-02 Cortecs Limited Pharmaceutical formulations
JPH06181725A (ja) * 1992-12-17 1994-07-05 Kiteii:Kk 易酸化性油状物の固形化剤
JP2004135681A (ja) * 1993-11-10 2004-05-13 Yakken:Kk 食品組成物
JPH07255436A (ja) * 1994-03-25 1995-10-09 Kiteii:Kk 複合飲料
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
GB9509764D0 (en) 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
US6531150B1 (en) * 1997-10-30 2003-03-11 Morishita Jintan Co., Ltd. Encapsulated unsaturated fatty acid substance and method for producing the same
CA2313024C (en) * 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
EP1075252A2 (en) * 1998-05-07 2001-02-14 ELAN CORPORATION, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
US20050037065A1 (en) 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
DK1157692T3 (da) 2000-05-22 2006-02-06 Pro Aparts Investimentos E Con Sammensætning af fedtsyrer indeholdende mindst 80 vægt-% EPA og DHA, derivater deraf og farmaceutisk anvendelse deraf
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
BR0309740A (pt) 2002-05-03 2005-02-22 Pronova Biocare As Uso de ácido eicosapentaenóico (epa), ácido docosaexaenóico (dha) ou de uma mistura de epa e dha ou de um sal ou derivado farmaceuticamente aceitáveis dos mesmos
SE0202188D0 (sv) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
US20040254357A1 (en) 2002-12-19 2004-12-16 Zaloga Gary P. Fatty acid phenolic conjugates
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
GB0413729D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
GB0413730D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
AU2005256322C1 (en) 2004-06-28 2011-07-07 Veloxis Pharmaceuticals, Inc. Porous tablets as carriers for liquid formulations
US20060051462A1 (en) 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
ES2489741T3 (es) * 2005-07-08 2014-09-02 Mochida Pharmaceutical Co., Ltd. Composición para la prevención de la aparición de acontecimientos cardiovasculares
ES2511772T3 (es) * 2005-12-20 2014-10-23 Cenestra, Llc Formulaciones de ácidos grasos omega-3
AU2007214127A1 (en) 2006-02-10 2007-08-16 Sportscom Danmark Aps Coated tablets, their methods of preparation, and related uses
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
WO2008113177A1 (en) * 2007-03-20 2008-09-25 Centre De Recherche Sur Les Biotechnologies Marines Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
US20090011012A1 (en) * 2007-07-06 2009-01-08 Baum Seth J Fatty acid compositions and methods of use
NZ600721A (en) * 2008-01-10 2013-03-28 Takeda Pharmaceutical Capsule formulation
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
WO2010040012A1 (en) * 2008-10-01 2010-04-08 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
EP2405902B1 (en) * 2009-03-09 2021-07-21 Basf As Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
CA3059911C (en) * 2009-05-22 2022-01-11 Mochida Pharmaceutical Co., Ltd. Self-emulsifying composition of .omega.3 fatty acid
US9717703B2 (en) * 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
KR20200013123A (ko) * 2009-10-23 2020-02-05 바스프 에이에스 지방산 오일 혼합물의 코팅된 캡슐 및 정제

Similar Documents

Publication Publication Date Title
JP6151317B2 (ja) 脂肪酸油混合物の被覆型カプセル剤および錠剤
US11523999B2 (en) Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof
JP2013508348A5 (cg-RX-API-DMAC7.html)
JP2013537186A (ja) 脂肪酸油混合物と遊離脂肪酸とスタチンとを含む組成物
JP2013537185A (ja) 遊離酸の形のｅｐａおよびｄｈａを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物
WO2013072767A1 (en) Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
TW201311294A (zh) 含脂肪酸油混合物、界面活性劑與司它汀（ｓｔａｔｉｎ）的組成物